Illinois 102nd Regular Session Status: In Committee 11 D cosponsors

SB 1623 — MEDICAID-MENTAL HEALTH-MEDS

Last action — Session Sine Die

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 102nd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

In plain language

The bill removes prior authorization for certain mental health medications under Medicaid programs.

This bill aims to facilitate quicker access to treatment for serious mental illnesses by eliminating prior authorization and management controls for certain medications covered by Medicaid. It applies to FDA-approved drugs identified by medical standards for mental health conditions.

What this means for you
  • Workers: This may improve access to mental health medications for workers enrolled in Medicaid.

Summary

Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, for the purpose of removing barriers to the timely treatment of serious mental illnesses, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA approved prescription drug that is recognized by a generally accepted standard medical reference as effective in the treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association. Senate Committee Amendment No. 1 Replaces everything after the enacting clause. Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, for the purpose of removing barriers to the timely treatment of serious mental illnesses, insurance cost containment prior authorization mandates and insurance utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA approved prescription drug that is recognized by a generally accepted standard medical reference as effective in the treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association.

Bill Text

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Session Sine Die

  2. Added as Co-Sponsor Sen. David Koehler

  3. Rule 3-9(a) / Re-referred to Assignments

  4. Added as Co-Sponsor Sen. Suzy Glowiak Hilton

  5. To Appropriations- Health

  6. Re-assigned to Appropriations

  7. Added as Co-Sponsor Sen. Julie A. Morrison

  8. Added as Chief Co-Sponsor Sen. Karina Villa

  9. Rule 2-10 Committee/3rd Reading Deadline Established As April 30, 2021

  10. Rule 3-9(a) / Re-referred to Assignments

  11. To Appropriations- Health

  12. Assigned to Appropriations

  13. Do Pass as Amended Behavioral and Mental Health; 007-004-000

  14. Senate Committee Amendment No. 1 Adopted

  15. Senate Committee Amendment No. 1 Assignments Refers to Behavioral and Mental Health

  16. Senate Committee Amendment No. 1 Filed with Secretary by Sen. Doris Turner

  17. Senate Committee Amendment No. 1 Referred to Assignments

  18. Postponed - Behavioral and Mental Health

  19. Added as Co-Sponsor Sen. Karina Villa

  20. Added as Co-Sponsor Sen. Sara Feigenholtz

  21. Postponed - Behavioral and Mental Health

  22. Added as Co-Sponsor Sen. Emil Jones, III

  23. Added as Co-Sponsor Sen. Adriane Johnson

  24. Added as Chief Co-Sponsor Sen. Jacqueline Y. Collins

  25. Added as Co-Sponsor Sen. Mattie Hunter

  26. Added as Chief Co-Sponsor Sen. Michael E. Hastings

  27. Assigned to Behavioral and Mental Health

  28. Directed to Multiple Committees Behavioral and Mental Health Committee, Appropriations-Health Subcommittee

  29. Referred to Assignments

  30. First Reading

  31. Filed with Secretary by Sen. Doris Turner

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 10 co-sponsors · 172 not signed on

Sponsors (1)

Co-sponsors (10)

Not signed on (172)

172 members have not signed on to this bill.

Show all 172 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1623 do?
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, for the purpose of removing barriers to the timely treatment of serious mental illnesses, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA approved prescription drug that is recognized by a generally accepted standard medical reference as effective in the treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association. Senate Committee Amendment No. 1 Replaces everything after the enacting clause. Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, for the purpose of removing barriers to the timely treatment of serious mental illnesses, insurance cost containment prior authorization mandates and insurance utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA approved prescription drug that is recognized by a generally accepted standard medical reference as effective in the treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association.
Who sponsors SB 1623?
SB 1623 is sponsored by Doris Turner (Democrat), Michael E. Hastings (Democrat), Karina Villa (Democrat), Mattie Hunter (Democrat), Adriane L. Johnson (Democrat), Emil Jones, III (Democrat), Sara Feigenholtz (Democrat), Julie A. Morrison (Democrat), David Koehler (Democrat), Suzy Glowiak Hilton (Democrat), and Lakesia Collins (Democrat).
What is the current status of SB 1623?
This bill died with 102nd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 1623?
Track SB 1623 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1623

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1623

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →